Canadian Journal of Anesthesia, Vol 41, 213-220, Copyright © 1994 by Canadian Anesthesiologists' Society

ARTICLES

Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487

JM Wierda, AM Beaufort, UW Kleef, NJ Smeulers and S Agoston
Department of Anesthesiology, University Hospital of Groningen, The Netherlands.

Three muscle relaxants, Org 9453, Org 9489 and Org 9487, short-acting in animals, were investigated to establish their profiles in humans. Potency, time course of action, and pharmacokinetic behaviour were studied in 90 healthy patients during fentanyl/halothane/N2O anaesthesia. Neuromuscular function was monitored mechanomyographically. Plasma and urine concentrations (three patients per compound) were measured by HPLC, and these data were analyzed by iterative linear least square regression analysis. The ED90 values for Org 9453, Org 9489 and Org 9487 were 1.4, 0.45 and 1.15 mg.kg-1 respectively. The onset times of Org 9453 (1.5 mg.kg-1, 1.1 X ED90), Org 9489 (0.9 mg.kg-1, 2 X ED90) and Org 9487 (1.5 mg.kg-1, 1.3 X ED90) were 1.2, 1.6 and 1.5 min, and the durations until 25% twitch recovery were 8.6, 22.0 and 8.9 min, respectively. Clearances of these doses were 6.9, 5.8, and 11.1 ml.kg-1.min-1, and mean residence times 26, 79, and 41 min, respectively. Mean renal excretion (parent compound and metabolites) within 24 hr amounted to 5, 11.3 and 12.2% respectively. No side effects other than a moderate short-lasting decrease of blood pressure and a concomittant increase in heart rate were noted. It is concluded that Org 9453 and Org 9487 are short-acting muscle relaxants in humans.

This article has been cited by other articles:

				N. J. Delboy, R. C. Tomichek, and J. A. Shields The Hemodynamic Effects of Rapacuronium in Patients with Coronary Artery Disease: Succinylcholine and Vecuronium Compared Anesth. Analg., May 1, 2002; 94(5): 1100 - 1106. [Abstract] [Full Text] [PDF]

				B. F. Vanacker, E. Geerts, S. Coppens, and M. van Iersel A Comparison of Neuromuscular Effects, Tracheal Intubating Conditions, and Reversibility of Rapacuronium Versus Mivacurium in Female Patients Anesth. Analg., April 1, 2002; 94(4): 876 - 878. [Abstract] [Full Text] [PDF]

				E. W. Moore and J. M. Hunter The new neuromuscular blocking agents: do they offer any advantages? Br. J. Anaesth., December 1, 2001; 87(6): 912 - 925. [Abstract] [Full Text] [PDF]

				G. E. Larijani, F. Donati, G. Bikhazi, R. Bartkowski, C. A. Kenaan, B. Plaud, and M. E. Goldberg A Multicenter Evaluation of the Time-Course of Action of Two Doses of Rapacuronium After Early and Late Reversal with Neostigmine Anesth. Analg., August 1, 2001; 93(2): 370 - 374. [Abstract] [Full Text] [PDF]

				T. J. Zhou, P. F. White, J. W. Chiu, G. P. Joshi, K. K. Dullye, L. L. Duffy, and W. K. Tongier Onset/offset characteristics and intubating conditions of rapacuronium: a comparison with rocuronium Br. J. Anaesth., August 1, 2000; 85(2): 246 - 250. [Abstract] [Full Text] [PDF]

				A. F. Kopman, M. M. Klewicka, and G. G. Neuman An Alternate Method for Estimating the Dose-Response Relationships of Neuromuscular Blocking Drugs Anesth. Analg., May 1, 2000; 90(5): 1191 - 1197. [Abstract] [Full Text] [PDF]